Insider Trading March 6, 2026

Muncy Columbia Financial EVP Purchases $30,801 in Stock as Shares Near 52-Week High

Loni N. Kline adds 498 shares on March 5, 2026; valuation metrics and InvestingPro analysis signal caution

By Hana Yamamoto CCFN
Muncy Columbia Financial EVP Purchases $30,801 in Stock as Shares Near 52-Week High
CCFN

Loni N. Kline, Executive Vice President and Chief Growth Officer of Muncy Columbia Financial Corp (CCFN), bought 498 shares on March 5, 2026, paying $61.85 per share for a total outlay of $30,801. The purchase occurred while the stock traded close to its 52-week peak and after a strong 12-month price gain; InvestingPro flags the stock as currently overvalued relative to its Fair Value estimate. The company reports a P/E ratio of 9.02 and a dividend yield of 2.97%.

Key Points

  • An executive-level insider, Loni N. Kline, purchased 498 shares of Muncy Columbia Financial Corp on March 5, 2026, for $61.85 per share, totaling $30,801.
  • The acquisition occurred while the stock was trading close to its 52-week high of $62.80 after a 47.6% gain over the past year; company valuation metrics show a P/E of 9.02 and a dividend yield of 2.97%, and InvestingPro reports the stock appears overvalued relative to its Fair Value estimate.
  • The trade was reported on a Form 4 filed with the SEC; following the purchase, Kline directly owns the 498 shares disclosed in the filing.

Loni N. Kline, who serves as Executive Vice President and Chief Growth Officer at Muncy Columbia Financial Corp (OTC: CCFN), completed a purchase of common stock on March 5, 2026. The transaction comprised 498 shares bought at $61.85 apiece, bringing the total value of the trade to $30,801.

The trade took place while the share price was trading near a 52-week high of $62.80. Over the previous 12 months the stock has posted a notable gain of 47.6%.

According to InvestingPro analysis cited in company data, the stock currently appears overvalued when compared to its Fair Value estimate. At the time of the transaction the company reported a price-to-earnings ratio of 9.02 and a dividend yield of 2.97%.

The buying activity was disclosed in a Form 4 filing submitted to the Securities and Exchange Commission. The filing indicates the transaction was a purchase; following the trade Kline directly holds 498 shares of Muncy Columbia Financial Corp.

This transaction links a named executive directly to the companys equity at a price point slightly below the 52-week high, with the purchased position representing the entirety of Klines disclosed direct holdings in the company per the filing.


Context and metrics included in the filing and public data:

  • Purchase date: March 5, 2026
  • Shares acquired: 498
  • Price per share: $61.85
  • Total transaction value: $30,801
  • 52-week high: $62.80
  • 12-month price change: +47.6%
  • P/E ratio: 9.02
  • Dividend yield: 2.97%

Where available, the information above is drawn from the companys Form 4 filing with the SEC and InvestingPros valuation commentary referenced in company disclosure. The filing confirms the transaction type and the post-trade direct ownership position held by Kline.

Risks

  • Valuation concern - InvestingPro analysis indicates the stock appears overvalued relative to its Fair Value estimate, which may affect investor expectations and market perception of the company - impacts the financials sector.
  • Price proximity to 52-week high - the purchase was made while shares traded near a 52-week high of $62.80 following a 47.6% one-year gain, which introduces uncertainty about near-term price upside - impacts equity markets and the financials sector.
  • Limited post-trade insider holding - the Form 4 shows Kline directly owns 498 shares after the transaction, a relatively modest disclosed holding that may limit the signal strength of the insider purchase - impacts investor interpretation within the financial services sector.

More from Insider Trading

CME Group General Counsel Sells $1.03M in Stock as Firm Reports Record Open Interest and Crypto Plans Mar 23, 2026 Neuronetics Insider Increases Stake With $238,955 Stock Purchase Mar 23, 2026 Insider Jorey Chernett Buys 25,000 Shares of Oncology Institute (TOI) for $83,750 Mar 23, 2026 Insider Jorey Chernett Adds $110,800 in AirSculpt Technologies Stock Mar 23, 2026 Airship AI Chief Executive Adds $89,688 in Stock While Shares Hover Near 52-Week Low Mar 23, 2026